FDA Approved: SILDENAFIL — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for sildenafil submitted by Chartwell RX, LLC under ANDA202598.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Pulmonary Arterial Hypertension

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

SUPPL AP for SILDENAFIL (SILDENAFIL)